Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

According to the International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization (WHO), stromal invasion, defined as destructive infiltrative growth, is the sole criterion used to distinguish serous borderline tumors from invasive serous carcinomas of the ovary. Although this criterion effectively identifies most malignant tumors, it does not permit the identification of a small subset of well-differentiated ovarian carcinomas that do not display destructive infiltrative growth but that may be associated with malignant behavior. In this study, we describe a group of such serous neoplasms that have distinctive morphologic features and that are often associated with progressive, invasive disease. We have designated these tumors micropapillary serous carcinomas (MPSC). They are characterized by a filigree pattern of highly complex micropapillae arising directly from large, bulbous papillary structures. The micropapillae are covered by round to cuboidal cells with a high nuclear-to-cytoplasmic ratio. Typical serous borderline tumors tend to display a hierarchical pattern of branching terminating in small papillae or tufts, and the cells covering the papillae tend to be more columnar and often ciliated compared with cells of MPSC. We reviewed more than 400 cases of serous ovarian borderline tumors and well-differentiated serous carcinomas and identified 26 cases of MPSC. Seventeen tumors lacked destructive infiltrative growth (noninvasive), and nine contained areas of invasion ranging from minimal to extensive. Eight of the 26 tumors were stage I, and none of the patients developed recurrence whether or not their tumors had demonstrable invasion. In contrast, of the 16 women presenting with stage II disease or higher and who had more than 1 year of follow-up, eight (50%) have either died of intra-abdominal carcinomatosis or are alive with carcinoma. Twenty-four (92%) of MPSCs contained areas of serous borderline tumor. The frequent association of MPSCs with serous borderline tumors suggests that MPSCs arise from the latter and may account for the few cases of serous borderline tumors that have been associated with progression to invasive carcinoma.

[1]  R. Kurman,et al.  Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. , 1996, The American journal of surgical pathology.

[2]  E. Yordan,et al.  Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Scully,et al.  Early de novo ovarian carcinoma. A study of fourteen cases , 1994, Cancer.

[4]  R. Kurman,et al.  The behavior of serous tumors of low malignant potential: are they ever malignant? , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  S. Ellenberg,et al.  Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials , 1990, The New England journal of medicine.

[6]  R. Scully,et al.  Ovarian serous borderline tumors with stromal microinvasion : a report of 21 cases , 1990 .

[7]  C. Gilks,et al.  Serous psammocarcinoma of the ovary and peritoneum. , 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  M. Weinstock,et al.  Peritoneal implants of ovarian serous borderline tumors: Histologic features and prognosis , 1988, Cancer.

[9]  F. Tavassoli Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  H. Merkur,et al.  Proliferating Ovarian “Epithelial” Tumours: A Clinico‐Pathological Analysis of 144 Cases , 1979, The Australian & New Zealand journal of obstetrics & gynaecology.

[11]  P. Russell The pathological assessment of ovarian neoplasms. II: The proliferating 'epithelial' tumours. , 1979, Pathology.

[12]  T. E. Morgan,et al.  Proliferative serous tumors of the ovary: Histologic features and prognosis , 1978, The American journal of surgical pathology.